NVCN

Stock ticker:
NASDAQ

77 days until earnings call

Intraday data for

Jan 12, 09:37 AM (EST)

Price

$0.49

Change

+$0.01 (+2.08%)

Capitalization

$32m

NVCN Price Prediction, Neovasc Stock Technical Analysis

a specialty medical device company that develops and manufactures products for the rapidly growing cardiovascular device marketplace

Industry @MedicalSpecialties

View Trends for NVCN(TRY FOR FREE)

Paper trades

Copy to...

Stock ticker: NASDAQ

NVCN

AS OF

Jan 12, 09:37 AM (EST)

Price

$0.49

Change

+$0.01 (+2.08%)

Capitalization

$32m

77 days until earnings call

NVCN Price Prediction, Neovasc Stock Technical Analysis

Stock market charts, price targets, analyst ratings and a financial calendar

a specialty medical device company that develops and manufactures products for the rapidly growing cardiovascular device marketplace

Industry @MedicalSpecialties

View Trends for NVCN(TRY FOR FREE)

Paper trades

Copy to...

A.I.dvisor published

NVCN Commentaries and news forecasts

9:00 AM EST Jan 12

REAL
TIME

NVCN (Neovasc): Weekly Commentary

Please wait a moment while the chart loads...

An error occurred while loading prices!

These past five trading days, the stock lost -0.06% with an average daily volume of 18778 shares traded. The stock tracked a drawdown of -9.53% for this period.

Please wait a moment while the chart loads...

An error occurred while loading prices!

AI Screener Basics

Expand

AI Screener FA & TA

Expand

Forecasts, Signals and Predictions about NVCN (Neovasc)

Technical Analysis	# Of Indicators	Avg. Odds
Bullish trend Bullish trend
Bearish trend Bearish trend
Bearish trend
Bullish trend

Fundamental Analysis	(1 - best, 100 - worst)

+332%

Swing Trader Crypto (ALGO, IOST, LINK, QTUM, NEO)

376 days traded

+353%

Swing Trader Crypto (ETH, LTC, BCH, ADA, BNB)

368 days traded

+67%

Long only Volume traders trailing

243 days traded

A.I.dvisor published

a Summary for NVCN with price predictions.

4:00 PM EST Jan 11

NVCN's RSI Indicator recovers from oversold territory

The RSI Oscillator for NVCN moved out of oversold territory on January 07, 2022. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Current price $0.49 crossed the resistance line at $0.85 and is trading between $0.85 resistance and $-0.09 support lines. Throughout the month of 12/09/21 - 01/11/22, the price experienced a -26% Downtrend. During the week of 01/04/22 - 01/11/22, the stock fell -0.91%.

A.I.dvisor published

Neovasc Earnings Data

NVCN is expected to report earnings to rise 18.18% to -12 cents per share on March 30

Q4'21

Est.

$-0.13

Q3'21

Beat

by $0.01

Q2'21

Missed

by $0.04

Q1'21

Beat

by $0.05

Q4'20

Beat

by $0.52

The last earnings report on November 09 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 12.93K shares outstanding, the current market capitalization sits at 32.01M.

Industry	Medical Specialties
Address	13562 Maycrest Way, Richmond, BC, V6V 2J7
Phone	+1 604 270-4344
Employees	71
Web	https://www.neovasc.com

Capitalization Capitalization	32M
P/E Ratio P/E Ratio	N/A
Risk (Beta) Risk (Beta)	2.14
Dividend Yield Dividend Yield	N/A
Total Cash Total Cash	63.3M
Total Cash/Share Total Cash/Share	0.94
Total Debt Total Debt	9.416M
Total Debt/Equity Total Debt/Equity	N/A
Projected Growth (PEG Ratio) Projected Growth (PEG Ratio)	N/A
Revenue/Share (as % of the share price) Revenue/Share (as % of the share price)	0%
Revenue Revenue	2.225M
ROE ROE	N/A
Book Value Book Value	63.4M
P/B Ratio P/B Ratio	0.56
Cash Flow Cash Flow	N/A
Earnings Earnings	-0.700
Average Daily Volume YTD Average Daily Volume YTD	N/A
Common Shares Outstanding - Security Level Common Shares Outstanding - Security Level	440M
Current Ratio Current Ratio	9.86
Current Revenue Per Employee Current Revenue Per Employee	8,916.45
Dividends Per Share - Security Dividends Per Share - Security	N/A
EBITDA EBITDA	-24,811,980
Float Float	N/A
Float - Current Float - Current	N/A
Gross Income Margin Gross Income Margin	82.77
Revenue To Assets Revenue To Assets	-53.41
Shares Held By Institutions Shares Held By Institutions	1.046M
Shares Outstanding - Current Shares Outstanding - Current	N/A
Total Liabilities Total Liabilities	17.6M
Total Volume MTD Total Volume MTD	N/A
Value	Fair
Gain YTD	2.433

Group	Domestic Stock Funds
Category	Medical Specialties
Total Expense Ratio Total Expense Ratio
Min. Initial Investment Min. Initial Investment	0.00 USD
Fund Existence Fund Existence	a few seconds ago
Turnover Turnover
Front Load Front Load
Net Assets Net Assets	0.00 USD
Manager Tenure Manager Tenure

Group	Domestic Stock Funds
Category	Medical Specialties
Capitalization Capitalization	32.01m USD
P/E Ratio P/E Ratio	N/A
Total Cash Total Cash	63.29m USD
Projected Growth Projected Growth	N/A
Total Debt Total Debt	9.42m USD
Revenue Revenue	2.23m USD
Risk (Beta) Risk (Beta)	2.14
Dividend Yield Dividend Yield	N/A
Total Cash/Share Total Cash/Share	0.94
Total Debt/Equity Total Debt/Equity	N/A
Revenue/Share Revenue/Share	0.00USD	as % of share price

Group	Domestic Stock Funds
Category	Medical Specialties
Net Assets Net Assets	0.00 USD
Fund Existence Fund Existence	a few seconds ago
Turnover Turnover
Capitalization Capitalization
Yield Yield
Total Expense Ratio Total Expense Ratio
Investment Style Investment Style
Risk (Beta) Risk (Beta)

Group	Domestic Stock Funds
Category	Medical Specialties
Market Capitalization	0.00 USD
Volume	0.00 USD

A.I.dvisor

published a Pattern (end of day)

Related Tickers to NVCN

Real Time

STOCK / NAME	PRICE $	CHG $	CHG %
		1 Day
BNGO	2.82	0.08	+2.92%
Bionano Genomics
ASXC	1.02	0.02	+2.00%
Asensus Surgical
MASS	19.98	-0.26	-1.28%
908 Devices
TMDI	0.61	-0.01	-1.61%
Titan Medical
SINT	0.61	-0.02	-3.17%
SiNtx Technologies

NVCN Price Prediction, Neovasc Stock Technical Analysis

Stock market charts, price targets, analyst ratings and a financial calendar

NVCN (Neovasc): Weekly Commentary

Forecasts, Signals and Predictions about NVCN (Neovasc)

NVCN's RSI Indicator recovers from oversold territory

Technical Analysis, Outlook, Fundamental Analysis READ MORE...

NVCN is expected to report earnings to rise 18.18% to -12 cents per share on March 30

General Information

Select Stock attributes to show

1 Day

NVCN (Neovasc): Weekly Commentary

Forecasts, Signals and Predictions about NVCN (Neovasc)

Technical Analysis, Outlook, Fundamental Analysis READ MORE...

General Information

Select Stock attributes to show

NVCN: pattern detected on

1 Day